Abbott Laboratories (ABT)
$135.82
0.00 (0.00%)
ABT Stock Quote Delayed 30 Minutes
7 Leading MedTech Stocks for Next-Gen Health Solutions
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
237.81B
PE Ratio
17.78
EPS
7.64
Volume (Avg. Vol.)
240
Day's Range
-
52-Week Range
$99.71 - $136.59
Dividend & Yield
$2.20 (1.62%)
ABT Stock Predictions, Articles, and Abbott Laboratories News
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector.
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
The 3 Best Healthcare Stocks to Buy in July 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
3 MedTech Stocks to Buy for Healthy Gains
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy.
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval
Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.
